These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21481328)

  • 1. Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age.
    Schmid P; Selak S; Keller M; Luhan B; Magyarics Z; Seidel S; Schlick P; Reinisch C; Lingnau K; Nagy E; Grubeck-Loebenstein B
    Vaccine; 2011 May; 29(23):3982-9. PubMed ID: 21481328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
    Villena J; Medina M; Racedo S; Alvarez S
    J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic protein contaminants in pneumococcal vaccines.
    Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
    J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children.
    Ditse Z; Adrian PV; Kuwanda L; Madhi SA
    Vaccine; 2013 Sep; 31(40):4421-7. PubMed ID: 23845819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease.
    Mureithi MW; Finn A; Ota MO; Zhang Q; Davenport V; Mitchell TJ; Williams NA; Adegbola RA; Heyderman RS
    J Infect Dis; 2009 Sep; 200(5):783-93. PubMed ID: 19642930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.
    Olafsdottir TA; Lingnau K; Nagy E; Jonsdottir I
    Infect Immun; 2012 Jan; 80(1):461-8. PubMed ID: 22025519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease.
    Baril L; Briles DE; Crozier P; King J; Punar M; Hollingshead SK; McCormick JB
    Vaccine; 2004 Dec; 23(6):789-93. PubMed ID: 15542203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT; Xu Q; Paton JC; Hollingshead SK; Pichichero ME; Briles DE; Girgis N; Zeng M
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
    Miyaji EN; Dias WO; Gamberini M; Gebara VC; Schenkman RP; Wild J; Riedl P; Reimann J; Schirmbeck R; Leite LC
    Vaccine; 2001 Dec; 20(5-6):805-12. PubMed ID: 11738744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy.
    Jakobsen H; Hannesdottir S; Bjarnarson SP; Schulz D; Trannoy E; Siegrist CA; Jonsdottir I
    Eur J Immunol; 2006 Feb; 36(2):287-95. PubMed ID: 16385627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X; Li B; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Zhang Y; Wu Y
    Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological responses to pneumococcal vaccine in frail older people.
    Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
    Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.
    Rapola S; Jäntti V; Haikala R; Syrjänen R; Carlone GM; Sampson JS; Briles DE; Paton JC; Takala AK; Kilpi TM; Käyhty H
    J Infect Dis; 2000 Oct; 182(4):1146-52. PubMed ID: 10979911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country.
    Lundgren A; Bhuiyan TR; Novak D; Kaim J; Reske A; Lu YJ; Qadri F; Malley R
    Vaccine; 2012 Jun; 30(26):3897-907. PubMed ID: 22504663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia.
    Andrade DC; Borges IC; Adrian PV; Meinke A; Barral A; Ruuskanen O; Käyhty H; Nascimento-Carvalho CM
    Pediatr Infect Dis J; 2016 Jun; 35(6):683-9. PubMed ID: 26954601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.